Background: A low incidence of thromboembolic events after successful catheter ablation of atrial fibrillation (AF) during a mid-term follow-up period was recently reported. However, because the incidence of such events over the long term is unknown, we investigated the late incidence of thromboembolic events after catheter ablation. Methods and Results: Patients with paroxysmal and persistent AF undergoing catheter ablation and being followed up for at least 24 months formed the study group (n=524); 82 patients (16%) had CHADS2 scores of at least 2. Mean follow-up was 44±13 months. Warfarin was discontinued in 400 (93%) of 429 patients (82% of 524 patients) without AF recurrence. None of the patients without AF recurrence suffered thromboembolic events, whereas 3 of 95 patients (3%) with AF recurrence did (P12 months after catheter ablation. There were 2 nonfatal major hemorrhagic events in patients with AF recurrence who continued on warfarin, but no hemorrhagic events were observed in patients free from AF (P=0.002). Conclusions: Maintenance of sinus rhythm after catheter ablation of AF was associated with a lower incidence of thromboembolic events during long-term follow-up >3 years. This result suggests that catheter ablation reduces thromboembolic events if patients continue anticoagulation regardless of the ablation outcome. (Circ J 2011; 75: 2343-2349)
Effective rhythm control of atrial fibrillation (AF) frequently bestows clinically meaningful advantages, such as increased exercise tolerance, improvement in symptoms, and prevention of atrial remodeling. The incidence of AF increases with the onset of congestive heart failure (CHF) and rhythm control is attempted in patients with AF and CHF in practice [ 1 x [1] The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation. Atrial fibrillation: current understanding and research imperatives. J Am Coll Cardiol. 1993; 22: 1830–1834 Abstract | Full Text PDF | PubMed | Scopus (107) | Google Scholar See all References , 2 x [2] Waldo, A.L. Management of atrial fibrillation: the need for AFFIRMative action. Am J Cardiol. 1999; 84: 698–700 Abstract | Full Text PDF | PubMed | Scopus (35) | Google Scholar See all References ].
16 March 2022 in Journal of Interventional Cardiac Electrophysiology
Purpose: The feasibility and safety of cavotricuspid isthmus (CTI) ablation with contiguous lesions using ablation index (AI) under the guidance of fluoroscopy integrated 3D mapping (CARTO UNIVU/CU) in typical atrial flutter (AFL) remains uncertain. This study aimed to determine the efficacy of AI-guided CTI ablation with contiguous lesions in patients with AFL. Methods: In this single-center, prospective, non-randomized, single-arm, observational study, procedural outcomes were determined in 151 patients undergoing AI-guided CTI ablation (AI group) with a target AI value of 450 and an interlesion distance of ≤ 4 mm under CU guidance. These outcomes were compared with those of 30 patients undergoing non-AI-guided ablation (non-AI group). Results: Among 151 patients, first-pass conduction block was achieved in 120 (80%) patients in the AI group (67% in the non-AI group, P = 0.152) with a shorter fluoroscopy time of 0.2 ± 0.4 min (1.7 ± 2.0 min in the non-AI group, P < 0.001). Conduction gaps were located at the atrial aspects near the inferior vena cava in 24 of 31 (78%) patients without first-pass conduction block. The AI group received 11 ± 5 (12 ± 4 in the non-AI group, P = 0.098) radiofrequency (RF) applications, and the RF time was 4.2 ± 2.4 (5.1 ± 2.5 min in the non-AI group, P = 0.011). Despite the occurrence of steam pop in 3 (2%) patients, none of them developed cardiac tamponade. No patients had recurrence within 6 months of follow-up. Conclusions: AI-guided CTI ablation in combination with CU was feasible and effective in reducing radiation exposure in patients with AFL.